Cypress Point Wealth Management’s Eterna Therapeutics ERNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-252
Closed -$16.8K 80
2025
Q1
$16.8K Hold
252
0.01% 68
2024
Q4
$27.7K Hold
252
0.01% 69
2024
Q3
$99.1K Hold
252
0.04% 74
2024
Q2
$173K Hold
252
0.08% 72
2024
Q1
$227K Hold
252
0.12% 69
2023
Q4
$169K Hold
252
0.13% 54
2023
Q3
$206K Hold
252
0.18% 50
2023
Q2
$213K Hold
252
0.23% 39
2023
Q1
$321K Hold
252
0.45% 34
2022
Q4
$304K Buy
+252
New +$355K 0.48% 31
2022
Q3
Sell
-252
Closed -$977K 26
2022
Q2
$977K Hold
252
1.71% 17
2022
Q1
$3.87M Hold
252
3.93% 8
2021
Q4
$7.87M Buy
252
+189
+300% +$10.3M 7.3% 3
2021
Q3
$4.39M Hold
63
3.13% 5
2021
Q2
$8.5M Buy
+63
New +$9.07M 6.04% 3

Other funds holding ERNA